Zepp Health reported second quarter 2026 revenue of US$63.5 million, up 6.9% year-over-year, with gross margin expanding to 37.4%. Net loss attributable to Zepp widened to US$11.3 million from US$7.7 million in the prior year period due to increased R&D and marketing investments offsetting higher revenue. Cash and restricted cash totaled US$106.3 million as of June 30, 2026. The company announced a price increase for its entire Bip family effective January 2027 to improve unit economics. Director Alain Lam resigned on September 1, 2026, citing responsibilities at Xiaomi. Management provided third quarter 2026 revenue guidance of US$68.0 million to US$73.0 million. Zepp Health Corporation operates in the smart wearable and health technology industry.